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Abstract.  The glycosaminoglycan chains of cell sur- 
face heparan sulfate proteoglycans are believed to 
regulate cell adhesion, proliferation, and extracellular 
matrix assembly, through their interactions with 
heparin-binding proteins (for review see Ruoslahti, E. 
1988. Annu.  Rev. Cell Biol.  4:229-255;  and Bernfield, 
M., R. Kokenyesi, M. Kato, M. T. Hinkes, J.  Spring, 
R. L. Gallo, and E. J. Lose.  1992.  Annu.  Rev. Cell 
Biol.  8:365-393).  Heparin-binding sites on many ex- 
tracellular matrix proteins have been described; how- 
ever, the beparin-binding site on type I collagen, a 
ubiquitous heparin-binding protein of the extracellular 
matrix, remains undescribed. Here we used heparin, a 
structural and functional analogue of heparan sulfate, 
as a probe to study the nature of the heparan sulfate 
proteoglycan-binding site on type I collagen. We used 
affinity coelectrophoresis to study the binding of hepa- 
tin to various forms of type I collagen, and electron 
microscopy to visualize the site(s) of interaction of 
heparin with type I collagen monomers and fibrils. 
Using affinity coelectrophoresis it was found that 
heparin has similar affinities for both procollagen and 
collagen fibrils (Kd'S ~,60-80 nM), suggesting that 
functionally similar heparin-binding sites exist in type 
I collagen independent of its aggregation state. Com- 
plexes of heparin-albumin-gold particles and procoLla- 
gen were visualized by rotary shadowing and electron 
microscopy, and a preferred site of heparin binding 
was observed near the NH2 terminus of procollagen. 
Native or reconstituted type I collagen fibrils showed 
one region of significant heparin-gold binding within 
each 67-nm period, present near the division between 
the overlap and gap zones, within the "a" bands re- 
gion. According to an accepted model of collagen 
fibril structure, our data are consistent with the pres- 
ence of a single preferred heparin-binding site near the 
NH2 terminus of the collagen monomer. Correlating 
these data with known type I collagen sequences, we 
suggest that the heparin-binding site in type I collagen 
may consist of a highly basic triple helical domain, in- 
cluding several amino acids known sometimes to func- 
tion as disaccharide acceptor sites. We propose that 
the heparin-binding site of type I collagen may play a 
key role in cell adhesion and migration within connec- 
tive tissues, or in the cell-directed assembly or re- 
structuring of the collagenous extracellular matrix. 
I 
NTERACTIONS between heparan sulfate  proteoglycans 
CHSPGs)  ~ and collagen fibrils are thought to play im- 
portant roles in cell adhesion (Koda et al., 1985; Piep- 
korn and Chapman, 1985), and in the formation of extracel- 
lular matrix structures such as basement membranes (Tslli- 
bary et al., 1988, 1990; Koliakos et al., 1989). It has been 
shown that HSPGs, heparan sulfates, and heparin each bind 
to type I collagen fibrils  (Stamataglou  and Keller,  1982; 
Keda et al., 1985; Keller et al., 1986; LeBaron et al., 1989). 
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The high affinity interaction between HSPGs or heparin and 
type I collagen fibrils is not common to other glycosamino- 
glycans (Koda et al., 1985; LeBaron et al., 1989). Further- 
more, the interaction  is completely disrupted by high salt, 
suggesting  a  primarily electrostatic basis  for the binding 
(Koda et al.,  1985; Keller et al.,  1986). It has also been 
demonstrated that the native character of the collagen triple 
helix is required for high affinity HSPG/heparin-type I col- 
lagen binding (Koda et al.,  1985; Keller et al.,  1986; San 
Antonio et al., 1992), and that the COOH-terminal triple he- 
lical fragment of type I collagen, as generated by vertebrate 
collagenase treatment, shows an apparently higher affinity 
for heparin than does the NH2-tenninal triple helical frag- 
ment (Keller et al., 1986). Aside from a requirement for tri- 
ple helical structure, the features of the type I collagen fibril 
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Thus, here we attempted to define the HSPG-binding  sites 
on type I collagen, owing to the likely  importance of these 
sites  in the  interactions  between cell  surfaces  and type I 
collagen- one of the most abundant molecules of the extra- 
cellular matrix. Thus, in this manuscript we have character- 
ized heparin-colhgen interactions by affinity coelectrophore- 
sis (ACE) and, using electron microscopy, sites of interaction 
were mapped for the binding of heparin-colloidal gold com- 
plexes to individual type I procollagen molecules and to both 
native and reconstituted  type I collagen fibrils. 
Materials and Methods 
Collagen Preparations 
Procollagen ~  I. Procollagen type I was isolated as detailed (Olsen et 
al., 1976). Briefly, leg tendons were dissected  from 17-d-old chick embryos, 
digested with trypsin and collagenase, and then the tendon fibroblasts were 
pelleted. Tendons from twelve dozen embryos yielded about 2  x  109 cells, 
which were placed in suspension culture for 6 h. Procollagen type I was 
isolated from the culture medium of the suspension cultures by ammonium 
sulfate precipitation with final protein yields of •1.5  mg observed. Procol- 
lagen type I purity was confirmed by SDS-PAGE analysis, and protein con- 
centration was determined by amino acid analysis, performed by the Bio- 
polymer Laboratory of the Brigham and Women's Hospital (Boston, MA). 
Collagen ~ype  I 
Acid Soluble. Collagen from rat tail tendons was isolated as described (San 
Antonio et al., 1992).  Briefly, tendons were subjected to three cycles of ex- 
traction/precipitation with 0.5 N  acetic acid/7.5%  NaCI,  and purity was 
confirmed by SDS-PAGE. 
Native.  Tendons were removed from the tails of 5-10 Long Evans rats 
and were placed in 0.1 M Tris HC1, 0.1 M NaC1, pH 7.5, with 1 mM PMSF 
and I mM EDTA. All procedures were conducted at 40C, and used the same 
buffer as detailed above. Tendons were rinsed several times in buffer, and 
were diced into pieces of ,,ol cm using a razor blade and scissors. The sam- 
pie was suspended in 100 ml of buffer, and homogenized at high speed in 
a food processor. The collagen was pelleted at 1,000 g/10 min, and the su- 
pernatant discarded. The pellet was resuspended in 100 rrd of buffer,  and 
was homogenized for 5 rain. Insoluble collagen was pelleted at 10,000 g/lO 
rain, the pellet was discarded, and the supematant passed through a thick 
layer of cotton gauze.  The  collagen was pelleted at  15,000  g/20  min, 
resuspended in 10 ml of buffer, then pelleted again at 15,000 g/20 min. The 
pellet was placed in <1 ml of buffer, dispersed by a brief sonication on ice, 
and samples were used in electron microscopy studies. Some samples were 
further treated with chondroitinase ABC. Fibril suspensions were diluted 
1:5 in enzyme buffer,  and were incubateA  with 0.05  U/ml cbondroitinase 
ABC  (Sigma Chem.  Co.,  St.  Louis,  MO)  for 3  h  at  37°C  (Koda and 
Bernfield, 1984).  Afterwards, fibril samples were pelleted and rinsed 2x 
in homogenization buffer,  and then used in electron microscopy studies. 
Heparin 
Heparin (grade I, porcine intestinal mucosa) was from Sigma Chem. Co. 
Heparin was substituted with tyramine at the polysaccharide's reducing end 
(San Antonio et al.,  1993),  radioiodinated to a specific activity of about 
30,000  cpm/ng, and  then radioiodinated low Mr  125I-Tyramine-labeled 
heparin chains (z25I-Tyr-heparin)  of Mr <6,000 were isolated by Sephadex 
G-100 chromatography (Laurent et al.,  1978; Jordan et al.,  1979;  Rosen- 
berg et al.,  1979).  Heparin-BSA-gold colloid (5-rim particles) was from 
Sigma Chem. Co., and BSA-gold colloid (5-aM particles) was from E. M. 
Sciences (Fort Vchshington,  PA). All other reagents used for ACE experi- 
ments were as described (Lee and Lander,  1991). 
ACE 
Procolingen 7),pc I. Procollagen samples were stored at 0.5-1.0 mg/ml in 
0.05 M ammonium acetate/ammonium bicarbonate, pH 7.8, and were pre- 
pared for ACE as detailed for other soluble proteins (Lee and Lander, 
1991). 
Acid Soluble ~e  1 Collagen. Acid soluble lyophilized collagen samples 
were dissolved in 0.5 N acetic acid at 2.4 mg/mi, with gentle stirring over- 
night at 4"C. Collagen was serially diluted in 0.5 N acetic acid. Samples 
were rapidly neutralized by the addition of  an equal volume of  0.5 N NaOH, 
mixed with  warm  2x  concentrated electrophoresis running  buffer and 
agarose, and then poured into agarose wells (San Antonio et al.,  1992). 
Electrophoresis of 1251-Tyr-heparin through agarose wells each containing 
one in a series of  concentrations of  protein was performed as described (Lee 
and Lander,  1991). 
Reconstituted  b'IbrUlar ~  I Collagen. Lyophilized collagen samples 
were dissolved in 0.5 N acetic acid at 1.2 mg/ml, with gentle stirring over- 
night at 4°C. Collagen was then dialyzed against 0.02 M Na2HPO4 for 48 h 
at 4°C. After dialysis the collagen formed a fibrous white precipitate. The 
sample was then sonicated with a steel probe sonicator (Braunosonic 1510; 
B. Braun Biotech haft., Melsungen, Germany) on ice with five pulses, with 
each lasting ~5 s, and with each spaced ,~15 s apart from the next pulse 
to avoid warming and melting the collagen. After this treatment the sample 
formed a visually homogenous milky white suspension. The collagen was 
serially diluted into the same phosphate buffer.  Samples were mixed with 
an equal volume of 2x ACE gel buffer salts, and then with an equal volume 
of 2×  agarose, and poured into agarose wells. Electrophoresis of heparin 
through these gels was as described above. 
Preparation of  Samples for Electron Microscopy of 
ProcoUagen-Heparin-Gold Complexes 
Procollagen was dialyzed into 0.2  M  potassium borate buffer (pH 8.0). 
BSA-heparin-gold 5-nm colloid was centrifuged 30 rain at 60,000 g and the 
pellet resuspended in a small volume of buffer.  The procollagen and hepa- 
fin-gold were mixed (25  ttg of procollagen plus 0.25 mi of concentrated 
5-um heparin-gold), allowed to bind for 15 rain at 25°C, and loaded into 
a Sepharose 4B column of 6.9-ml bed volume poured and equilibrated in 
0.2 M (NH4)2 CO3 (pH 8.25). In some cases the reaction mixture was fixed 
with glntaraldehyde before loading on the column. The column was ehited 
at '~5 ml/h and fractions of 0.2 mi were collected and analyzed by elec- 
trophoresis for protein, and by measuring As20 to monitor heparin-gold 
content. Generally the first three fractions after the void volume were used 
for electron microscopy. Samples were prepared for electron microscopy as 
described by Margossian et al.  (1991). 
Electron Microscopy  of ProcoUagen 
Approximately 20-#g/ml solutions of complex were mixed with 0.25 vol of 
glycerol, sprayed on to freshly cleaved mica, dried in vacuo for 20 h, and 
rotary shadowed with platinum or tungsten by means of  resistive or electron 
bombardment heating, respectively (Slayter,  1976, 1983). The estimated av- 
erage metal-film mass thickness was 100 ng/cm  2 for tungsten and some- 
what more for platinum. Samples were examined in the JEM 100CX elec- 
tron microscope, using a top entry stage voltage with a 40-/zm objective 
aperture,  and  at  100  kV acceleration voltage.  Most micrographs were 
recorded at a magnification of 20,000x  and enlarged photographically to 
50,000 or 100,000 ×. High resolution darkfield images were also obtained, 
from the lightly shadowed specimens, by using matched annular condenser 
and objective apertures (Slayter,  1989,  1991). 
Electron Microscopy of Fibrous Collagen 
Reconstituted and native type I collagen fibrils were prepared as detailed 
above.  Specimens of fibrous collagen were deposited on carbon-filmed 
grids, incubated at 4"C with heparin-gold for 30 rain, washed with 0.1 M 
cacodylate buffer, pH 7.4, fixed 5 min with 0.25% glutaraldehyde in 0.1 M 
cacodylate buffer at pH 7.0, washed 3 ×  with water, and then stained with 
1% uranyl acetate without thorough poststain washing (Slayter,  1983). Cali- 
bration was based on micrographs of grating-replica standards and of  Indan- 
threne Olive crystals (Labaw,  1964). 
Electron Microscopy of Frozen Sections 
Blocks of rat tail tendon (0.5 ram) were fixed for 1 h in 0.1% glutaraldehyde 
in Stefanini (1967) fixative (4% paraformaldebyde, 15%  saturated in neu- 
tralized picric acid). Tissue blocks were then immersed overnight at 40C 
in PBS containing 2.3 M sucrose. These were maintained in a liquid nitro- 
gen refrigerator until use, for a minimum of  24 h. Specimen blocks mounted 
on cutting stubs were removed and sections were obtained with thickness 
"~60 nm. The methods used are essentially those of  Tokoyasu and coworkers 
(Tokoyasu and Singer, 1976; Tokoyasu et al., 1983) as modified by Watkins 
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tome fitted with an FC4D cryochamber  (Vienna, Austria) at a temperature 
range of -110 to -130"C. The sections were mounted  on Formvar/carbon- 
coated 200-mesh inch  -1 grids and labeled as previously  described (Geuze 
et al., 1981). Sections were labeled by 30-min incubations with heparin- 
gold at '~60/~g/ml, washed, counterstained with uranyl acetate, and em- 
bedded in  1.25% methylcellulose as previously described (Watkins et 
al.,  1991). Sections were examined with a JEOL 100CX electron micro- 
scope at 20,000x using a 40-tan objective aperture (JEOL U.S.A. Inc., 
Peabody, MA). 
Results 
Binding of Heparin to Different Forms 
of 1)ppe I Collagen 
The  binding  interaction  of heparin  with  monomeric  and 
fibrillar  collagen was  studied  using ACE.  Type I  collagen 
was  incorporated  into  ACE  gels  in  the  following  forms: 
procollagen type I (collagen monomers); reconstituted, acid- 
solubilized type I collagen, and reconstituted,  fibrillar type 
I  collagen.  Electrophoresis  of  125I-Tyr-heparin  was  con- 
ducted through the collagen-containing  lanes  of ACE gels 
and electrophoretograms are shown in Fig. 1 a. Retardation 
coefficients (R) of the heparin migration fronts within each 
ACE gel lane were measured, and are plotted versus protein 
concentration (Fig.  I b). From these curves the apparent av- 
erage Kd'S of the binding between heparin and the collagen 
preparations  were  derived.  In  two  experiments,  apparent 
Kd's (in nM)  for heparin binding were: procollagen, 58  5- 
2; acid soluble collagen, 79  +  16; fibrillar collagen, 79  5- 
14. These data indicate that the apparent affinities exhibited 
by  each  of the  collagen  preparations  for heparin  are  not 
significantly different from each other.  Furthermore,  these 
affinities are in the range of those exhibited by other heparin- 
binding proteins for heparin (Lee and Lander, 1991; San An- 
tonio et al.,  1993). 
Figure 1. (a) ACE analysis of the interactions  between low Mr 1251- 
Tyr-heparin and various forms of type I collagen.  ACE gels were 
constructed containing type I  collagen in the procollagen,  acid 
solubilized,  or reconstituted,  fibrillar form. Collagens were present 
in gel lanes at the concentration (nM) indicated beneath each lane, 
with Mr's taken to be 450 K  for procollagen, and 300 K for the 
other  forms.  Radiolabeled  heparin  was  loaded  into  a  sample 
slot (located  above each gel),  and electrophoresis  was conducted 
towards  the anode 0ocated below each gel).  Images of heparin 
migration patterns within  ACE gels were obtained using a phos- 
phorimager (Molecular  Dynamics).  From these  electrophoreto- 
grams, the dissociation constant (Kd) Can be estimated  from the 
protein concentration at which the heparin is half-shifted  from be- 
ing  fully mobile at very low protein concentrations or between 
protein-containing lanes, to being maximally retarded at high pro- 
tein  concentrations  (Lee and  Lander,  1991). (b)  Calculation of 
affinities of low Mr heparin for different  forms of type I collagen. 
Radiolabeled  heparin was subjected  to ACE analysis  against  the 
various collagen preparations as illustrated  in (a). Heparin retarda- 
tion coefficients (R) within each collagen-containing lane were de- 
termined (see Materials  and Methods) and are plotted against pro- 
tein concentration.  Smooth curves represent nonlinear least-squares 
fits to the equation R  =  R®/(1 + Kd/[protein]2). 
Figure 2.  Chromatography  of procollagen  heparin-gold  com- 
plexes on a Sepharose  4B column. Graph shows the elution of the 
heparin-gold reagent  as determined by measuring A520 of column 
fractions.  Void volume is at fraction 14. (Inset) ProcoUagen content 
of column fractions was monitored by PAGE, followed by silver 
staining.  Lane 1, standards  including 5 bands of highest  staining 
intensity  represent  proteins  of Mr 200,  116, 97, 66, and 45 K; lane 
2, ,x,l.0 #g procollagen type I from stock solution; lane 3, procolla- 
gen from column fraction 17, representing  about 5 % of protein in 
fraction.  Pro cd and pro ct2 chains of procollagen molecules are 
indicated.  Specimens for electron microscopy were taken generally 
in the range from fractions 16 to 22. 
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of  procollagen  heparin-gold 
complexes showing procoUa- 
gen (lst frame) and a variety of 
complexes observed by rotary 
shadowing. The first five rows 
of microgral~s show monomo- 
lecular comple~s between  pro- 
collagen and heparin-gold. Mi- 
crographs in rows six through 
nine show complexes of pro- 
collagen  molecules  held  to- 
gether  at  one  or  more  po- 
sitions  by  heparin-gold. 
Bottom row width,  1500 nm. 
Visualization of  Heparin-binding Sites on ~  I 
Collagen Monomers and ~brils 
Mapping of  Procollagen. To map the heparin-binding site on 
collagen monomers, electron microscopy was used to exam- 
ine complexes between heparin-gold reagent and procolla- 
gen in solution. Rotary-shadowed preparations were made of 
the material obtained from the excluded volume of the gel 
filtration step used to separate unbound heparin-gold from 
that which is complexed with the procoUagen (Fig. 2).  We 
obtained micrographs of the complex material mixed with 
unbound procoUagen. In the course of these experiments it 
was discovered that the fraction excluded at the column-void 
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Figure  4.  Histograms  show 
mapping of the  ~aositions of 
heparin-gold  on procollagen 
molecules in rotary-shadowed 
preparations of molecular  com- 
plexes.  Position  of heparin- 
gold particles  was  measured 
from the center of  the COOH- 
terminal  globular  head  to- 
wards  the  NH2  terminus  of 
procollagen. Molecular com- 
plexes  were  fixed  in:  (a) 
0.01%;  (b)  0.0001%;  (c) 
0.00002 % glutaraldehyde be- 
fore column chromatography 
and rotary shadowing. In all 
cases there is a principle high 
frequency position of heparin- 
gold attachment at ,x,300 mn 
from the center of the COOH- 
terminal head of procollagen. 
volume (fraction 17) contained a large proportion of large in- 
termolecularly cross-linked collagen complexes associated 
with  some  heparin-gold,  but  that  individual  procollagen 
complexes with  heparin-gold  reagent  were  rare.  On  the 
other hand, fraction 22 contained a much greater proportion 
of monomolecular complexes. Complexes representative of 
the variety encountered are shown in Fig. 3, including some 
containing more than one procollagen molecule. Procolla- 
gen is shown in Fig. 3 (upper left) with the characteristic 10- 
rim head.  In the first five rows of selected micrographs of 
complexes  of a  single  procollagen  molecule  with  hepa- 
fin-gold, the position of binding is clearly identified by the 
characteristic gold colloid particle with a dense core. In rows 
6-9,  complexes are  illustrated  in  which procollagens are 
bound together by a single multivalent heparin-gold colloid 
particle.  The  positions  of the  heparin-gold  particles  on 
procollagen molecules were measured for complexes ob- 
tained under different experimental conditions. Fig. 4 sum- 
mafizes the location of  hepafin-gold particles in several rep- 
resentative  experiments  as  a  function  of  their  position 
relative to the center of the COOH-terminal head of procol- 
lagen.  The histograms  show  a  principal  peak of heparin 
binding near the NH~ terminus of procollagen. Quantitative 
results are summarized in Table I. 
To stabilize complexes, we subjected them to glutaralde- 
hyde fixation,  using a  series of glutaraldehyde concentra- 
tions,  buffered  to  neutrality.  The  fixation  reaction  was 
stopped by adding an excess of glycine to block unbound 
glutaraldehyde, thus minimizing both intramolecular cross- 
linking between procollagen molecules and background due 
to  possible  nonspecific  cross-linking  between  the  hepa- 
fin-gold and procollagen. Preferred regions of heparin-gold 
Table L Summary of  Heparin-Gold-Procollagen 
EM Mapping Data 
Experi-  GA Concert-  Histogram 
ment  tration  %  peaks 
nm* 
1  0  195  maj  290 min 
2  0  20  -  260 maj 
3  .00002  Head/10 maj  -  280 maj 
4  .0001  Head/10  min  -  280 maj 
5  .01  -  -  280 maj 
6  .01  -  -  290 maj 
* Distance in ran from COOH terminus, or center of head, in procollagen, to 
center of heparin-gold  marker. 
GA, glutaraldehyde;  maj, major peak; rain,  minor peak (collagen  =  328 nm 
in same experiment). 
binding were found in all of the experiments (Fig. 4), and 
the data are summarized in Table I. Most of the heparin-gold 
is found at a site very near the tail end of the molecule. The 
peak at •10-20  nm from the head, is somewhat suppressed 
at the higher glutaraldehyde concentrations (Fig. 4, a and b), 
but the other peak *290 nm from the head (very near the 
tall end),  is always maintained (Fig.  4).  Validity of these 
results was supported by a control experiment in which bo- 
vine serum albumin complexed with gold was used in map- 
ping experiments and failed to bind to procollagen (data not 
shown). 
Mapping of Reconstituted  Collagen Fibrils. Our finding 
of one preferred heparin-binding site on procollagen mono- 
mers led us to determine if hepafin-binding sites are also 
available in the type I collagen fibril, which is a structure 
composed of overlapping collagen monomers. Thus, map- 
ping  experiments were undertaken  with  several forms of 
fibrous collagen. Labeled fibrils were selected and scored for 
the position of the heparin-gold particles in relation to the 
67-nm repeat of native-type fibrils, measuring from the be- 
ginning of the overlap zone (Fig. 5 c, arrow) toward the gap 
zone. Fig. 5 c shows a typical type I collagen fibril heavily 
labeled with heparin-gold in the region of the "a" bands. The 
data were plotted as histograms and are shown in Fig. 6. A 
single major peak is clearly evident in Fig. 6 a at a position 
,,o35 nm from the origin, with a possible minor peak at 65 
nm. No other significant hot spot is seen in this profile. The 
experiment was  repeated several times and, always, major 
peaks at "°30--35  nm were found as indicated in Table II. 
Mapping  of Native  Collagen Fibrils. We  next  tested 
whether the beparin-binding sites we observed in reconsti- 
tuted collagen fibrils might be available for heparin binding 
in native fibrils in vivo, by examining heparin-gold binding 
by native collagen not only in preparations of homogenized 
rat tall tendon, but also in frozen sections of rat tall. Isolated 
native fibrils from homogenized tendon, and frozen sections 
of  unfixed rat tendon when stained with heparin-gold, showed 
a major peak at "-30 nm from the head and a minor peak at 
,,o62 nm from the head (Fig. 6, b and c). Table II summarizes 
the results of a number of different experiments. A control 
experiment was performed in which the access of heparin- 
gold was blocked by the presence of heparin (•200  #g/ml). 
Under these conditions the major peak of  heparin-gold bind- 
ing at the center of the molecule virtually disappeared. 
Effect of  Chondroitinase upon Mapping of  Native Colla- 
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ing data obtained for the bind- 
ing of heparin-gold to procol- 
lagen type I  and  to collagen 
type  I  fibrils.  (a)  Darkfield 
electron  micrograph of tung- 
sten  rotary-shadowed  prepa- 
ration  of  procollagen  show- 
ing globular COOH-terminal 
head on right, and position of 
putative  heparin binding  site 
(black arrow) as deduced  by 
mapping data in Fig.  4.  The 
location  of  the  COOH-ter- 
minal  end  of  tropocollagen 
and of the preferred heparin- 
binding site relative to the mo- 
lecular  overlap model of the 
collagen fibril is indicated by 
the  dotted  lines.  (b)  Dia- 
gram showing the arrangement 
of  tropocollagen  monomers 
within the collagen fibril, rel- 
ative  to  the  location  of the 
overlap  and  gap  zone  fibril 
staining pattern. This molecu- 
lar  model  was  proposed  by 
Chapman (1974).  Tropocolla- 
gen  molecules  are  shown  as 
horizontal rods, and the polar- 
ity  of  all  monomers  in  the 
fibril is indicated by N  (NH2 
terminus)  and  C  (COOH 
terminus)  markings  on  one 
monomer.  A  diagram of the 
molecules  within  one  67-nm 
period  (boxed  area)  is  also 
shown expanded in Fig. 7. (c) 
Electron  micrograph  of glu- 
taraldehyde-fixed,  heparin- 
gold  type  I  collagen  fibril 
complexes,  in  fibrils  visual- 
ized by uranyl acetate  stain- 
ing. Letters below micrograph 
show  positions  of positively 
stained fibril bands, following 
the  accepted notation  (Gross 
and  Schmitt,  1948).  Dotted 
lines between molecular model in b and the electron micrograph show corresponding overlap and gap zones. The location of heparin-gold 
particles relative to the molecular structure of the fibril as presented in Fig. 6 was measured within each 67-nm period, beginning at the 
center of the left border of the overlap zone (origin, arrow), and extending to the center of the right border of the gap zone. Heparin-gold 
particles appear as circular dark objects present mainly in the "a" bands region of the fibrils. 
gen  Fibrils.  In  another  series  of  experiments  the  hepa- 
rin-gold-binding  site of native rat tail type I  collagen  was 
mapped before and after treatment of the collagen fibrils with 
chondroitinase.  It was thought that chondroitinase treatment 
might uncover sites on collagen fibrils that are masked by en- 
dogenous proteoglycans such as decorin, thus making map- 
ping of heparin-binding  sites more definitive. In two experi- 
ments, the primary binding site was ,'~30 nm from the head. 
A second minor site at •65  nm became somewhat more dis- 
crete after the chondroitinase  treatment,  but overall,  chon- 
droitinase  treatment  of  fibrils  had  little  effect  on  hepa- 
rin-gold  binding  to  fibrils.  Table  II  shows  histograms 
summarizing  the  data  from these  experiments.  Since  seg- 
ment long spacing preparations of type I collagen are formed 
at low pH in acetic acid, and heparin-gold is unstable under 
these conditions,  mapping experiments were found not pos- 
sible to conduct  on segment long  spacing fibrils. 
For the  mapping  experiments,  the  potential  error  in  as- 
signing positions on the basis of the heparin-gold label pro- 
cedure is dependent upon several factors. First, the albumin- 
heparin-gold complex is '~10 nm in diameter. (The complex 
is  visualized  to  be  10  nm  in  the  metal-coated  molecular 
preparations but only the 5-nm gold core is visualized in the 
fibrillar  preparations.)  Second,  this  marker  could  attach 
from the left,  right,  above,  or below relative to the actual 
binding site. Third, some shrinkage upon dehydration (up to 
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Figure  6.  Histograms  show 
mapping of the positions  of 
heparin-gold  on  (a)  recon- 
stituted type I collagen fibrils; 
(b) native fibrils from homog- 
enized  rat  tail  tendons;  (c) 
fibrils in frozen sections of na- 
tive rat tail  tendon.  The lo- 
cation of heparin-gold  parti- 
cles relative to the molecular 
structure of the fibril (see Fig. 
5) was measured within each 
67-nm  period,  beginning  at 
the center of the left border of 
the overlap zone, and extend- 
ing to the center of the fight 
border of the gap zone. In all 
cases there is a principal high 
frequency  position  of hepa- 
rin-gold  attachment  at  '~30 
nm from the beginning of the 
overlap zone toward the gap 
zone, in the "a" (see Figs. 5 c 
and  7)  bands  region  of the 
fibril. 
10%) may be expected in procollagen. Finally, markers may 
detach slightly prior to or during fixation. However, the data 
show a number of rather narrow (10 nm, two histogram bars) 
histogram maxima peaks. It is thus concluded that all factors 
mentioned other than the marker size must be of lesser im- 
portance and suggest that the error is roughly the size of the 
marker. 
Discussion 
Here, we have explored the nature of  heparin binding by type 
I collagen monomers and fibrils. In the first series of  electron 
microscopy experiments, heparin binding to type I procolla- 
gen was studied, as procollagen remains in the monomeric 
state. Since procollagen retains its COOH-terminal globular 
head, the polarity of the molecules can be readily identified. 
Histograms of procollagen-heparin-gold mapping experi- 
ments include data from complexes that were unfixed as well 
as complexes fixed using three different glutaraldehyde con- 
centrations. In all cases there was a preferred site of attach- 
merit of heparin-gold near the NH2-terminal end, positioned 
•290  nm from the head-neck juncture of the procoUagen 
molecule. In addition, in several preparations there was evi- 
dence of other apparently weaker sites that appear at lower 
concentrations of glutaraldehyde, or in the absence of fixa- 
tion, at the COOH-terminal end, or at a position '~10-20 nm 
from the COOH-terminal end, starting from the head-neck 
junction. It is interesting that the COOH-terminal binding site 
is missing in the preparations of complexes which were fixed 
at  high  concentrations  of glutaraldehyde,  suggesting  that 
glutaraldehyde treatment has eliminated that site either by 
amino derivitization or by modifying collagen conformation. 
The  principle  heparin-binding  site  on  type  I  collagen 
Table II. Summary of  Heparin-Gold-Collagen  Fibril 
EM Mapping Data 
Histogram 
Experiment  Description  peak 
nm 
7  Reconstituted collagen  30 
8  Reconstituted collagen  32 
9  Reconstituted collagen  30 
10  Native collagen fibrils  30 
11  Chondroitinase treated; native  30 
collagen fibrils 
12  Native fibrils  27 
13  Chondroitinase treated; native  27 
collagen fibrils 
14  Frozen section of nonfixed  27 
rat connective tissue 
fibrils was found near the interface between the overlap and 
gap region in the vicinity of the "a  " bands as shown in Fig. 
6.  Experiments substantiated that this heparin-binding site 
occurs in this same position in reconstituted type I collagen 
fibrils, as well as in those of native tissue, and in fibrils from 
homogenized rat tail tendons. The correlation between the 
results  from the  mapping  of the  heparin-binding  site  on 
procoUagen with that of fibrils was facilitated using the over- 
lap  model presented by Chapman,  1974  (Fig.  5).  In this 
model, the =a" bands contain elements of the NH~ terminus. 
Therefore, our finding that heparin attaches primarily to 
site(s) near the NH2 terminus of procollagen is compatible 
with the presence of a preferred binding site located near the 
division between the overlap and the gap zone in the fibrils, 
in the "a" bands region (see Fig. 5). All of the results with 
monomolecular complexes were obtained with type I procol- 
lagen obtained from chicken tendon fibroblasts.  However, 
the experiments on fibrils used both native-type I collagen 
fibrils, and purified reconstituted native-type collagen fibrils 
from rat tail tendon. Given that the structural features of  type 
I  collagen are highly  conserved, the  comparison is  most 
likely valid (Monson et al.,  1982). 
It is important to determine the level of structural organi- 
zation of the collagen fibril required for high affinity heparin 
binding. Previous work has shown that monomeric tropocol- 
lagen binds heparin (Obrink, 1973), and that disrupting the 
triple helical conformation by melting of the collagen sig- 
nificantly reduces its heparin-binding affinity (Koda et al., 
1985; Keller et al.,  1986; San Antonio et al., 1992). In this 
report we have shown that type I procollagen and fibriUar 
type I collagen display similar binding affinities for low mo- 
lecular  weight heparin.  Our  finding  that heparin-binding 
sites are available for the binding of heparin-gold not only 
in reconstituted collagen fibrils, but also in native collagen 
fibrils, which are complex structures composed of types I, 
III, and V collagen molecules, is also considered significant. 
In principle, one might expect fibrillar collagen to exhibit a 
higher apparent affinity than procoUagen for heparin, since 
fibrils are potentially multivalent ligands.  The fact that a 
higher apparent affinity was not seen suggests that any im- 
provement in binding affinity due to multivalency is effec- 
tively offset in fibrils by a decrease in numbers of binding 
sites that are available. Such a decrease is expected, in fact, 
since a significant fraction of the collagen monomers in a 
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sumably unavailable for binding. 
Others have reported that when vertebrate collagenase was 
used to cleave type I collagen, the COOH-terminal fragment 
bound to a heparin affinity column more tightly than did the 
larger NH2-terminal  fragment (Keller et al., 1986).  This is 
contrary to our finding of a preferred binding site near the 
NH2 terminus, but there are ways in which this discrepancy 
may be explained. For example, it is possible that a cryptic 
heparin-binding site in the COOH-terminal region of type I 
collagen is made accessible for heparin binding only after 
collagenase treatment. Alternatively, differences in the char- 
acteristics (e.g., size, multivalency) of the heparin-gold re- 
agent used in the present study and the affinity matrix used 
by Keller et al. (1986), may give rise to differences in acces- 
sibility of heparin-binding sites to these two reagents. 
It has been proposed that heparin-binding sequences in 
many proteins consist of clusters of three to five basic amino 
acids, interspersed with hydropathic amino acids, and pres- 
ent within an ot helical conformation (Cardin and Weintraub, 
1989). When we searched the complete sequences of the otl 
and c~2 chains of human type I procollagens (Kuivaniemi et 
al., 1988; Tromp et al., 1988) for such consensus sequences, 
none were found. Thus it appears that type I collagen uses 
novel types of binding sites  to interact with heparin and 
HSPGs. As an approach to identifying the heparin-binding 
sites on type I collagen, we examined our data showing that 
the primary heparin-binding site on procollagen is located 
near the NH~ terminus of the molecule, and that within the 
fibril the preferred heparin-binding site falls in the "a  " bands 
region (see Figs. 5 c and 7).  We inspected the amino acid 
sequences of the od and or2 chains of type I collagen in rela- 
tion to the location of heparin binding we observed in the 
monomer and the fibril. In these regions of the collagen tri- 
ple  helices,  we  concentrated on locating amino  acid se- 
quences of net basic charge which might prove suitable as 
binding sites for the polyanion heparin.  Interestingly, one 
highly basic sequence was found in the triple helix near the 
NH2-terminal end of procoUagen,  as well as within the "a" 
band region of the fibril, and is present in type I collagens 
of human, bovine, rat, and chick (Kuivaniemi et al.,  1988; 
Hulmes et al., 1973; Tromp et al., 1988) (Fig. 7). This locus 
consists of nine basic amino acids, six of them contributed 
by the otl chains, and three by the o~2 chain, as shown below: 
cd:  hlys-gly-his-arg-gly-phe 
c~2:  hlys-gly-ile-arg-gly-his 
In the cd chain of rat tropocollagen, this site includes amino 
acid residues 87-92 (Hulmes et al., 1973). Three of  the basic 
amino acids within this sequence are hydroxylysine  residues, 
which are  involved in  cross-links,  and which  sometimes 
function as dissacharide acceptor sites (Buffer and Cunning- 
ham, 1965, 1966).  We propose that this domain may func- 
tion as a heparin-binding site in type I collagen. It should be 
stressed that there are other clusters of basic amino acids lo- 
cated in the collagen triple helices constituting the "a" band 
fibril region, but these all include fewer basic amino acids 
than the site discussed above, and often are present in close 
proximity to triple helical domains carrying strong negative 
charges (Fig. 7). 
In the type I collagen monomer one other highly basic do- 
main exists in the triple helix near the carboxy terminus (Fig. 
7, arrow 7), and it also contains hydroxylysine residues in- 
volved in cross-links (Butler and Cunningham, 1966).  The 
domain carries eight positive charges, and differs from the 
primary sequences of our proposed heparin-binding site, in 
both the composition and arrangement of some of its posi- 
tively charged amino acids. It is possible that the weak hepa- 
rin binding we observed near the COOH-terminal end of 
procollagen (Fig. 4, b and c) may be partially or wholly due 
to heparin binding to the COOH-terminal basic domain de- 
scribed above. In fact, this same site could be responsible for 
the heparin-binding affinity attributed to the COOH-terminal 
portion of type I collagen (Keller et al., 1986). The potential 
error in positioning the heparin-gold reagent relative to pro- 
collagen, however, makes it difficult at present to distinguish 
between binding of heparin-gold to the putative COOH- 
terminal heparin-b'mding sequence, as opposed to other basic 
domains near or on the globular head of procollagen. 
It has been predicted that the proteoglycan-binding site 
should be in the "a" and "c2" band regions of the type I colla- 
gen fibril (see Figs. 5 c and 7), based on fibril staining pat- 
terns,  as  well  as  the  concentration of unpaired  positive 
charges of the combined rat and bovine sequences of the t~l 
chains (Doyle et al.,  1975).  It is significant in the present 
study that we observed heparin binding mainly to the "a" 
bands of native type I collagen. Previous work showed, how- 
ever, that in tissues the location of  various types of  proteogly- 
cans (e.g., dermatan and keratan sulfate PGs) on type I col- 
lagen fibrils is not limited to the "a" bands region, but can 
also occur within the "c, "d" or "e" bands regions (see Figs. 
5 c and 7) of the 67-nm period (for review see Ruoslahti, 
1988;  Scott, 1988, 1991). Further work is necessary to de- 
termine if in vivo cell surface or extracellular matrix forms 
of HSPGs preferentially occupy the "a" bands region of type 
I collagen fibrils. 
The relationships between the cell-attachment sites of type 
I collagen fibrils and heparin-binding sites are of great in- 
terest because heparin and syndecan-1 block cell adhesion to 
type I  collagen in vitro (Koda et al.,  1985;  Piepkorn and 
Chapman, 1985). It is proposed that proteoglycans have this 
effect because they bind extracellular matrix molecules at 
sites that are adjacent to cell-attachment sites and thereby 
sterically hinder the binding of cell surface integrin recep- 
tors (Brennan et al.,  1983). 
The  spatial  relationship between the  putative heparin- 
binding site and various potential cell-attachment sites on 
collagen fibrils are considered in Fig. 7. An average heparin 
molecule of 15,000 D is ~30-nm long. If collagen-binding 
sites on heparin consist of randomly distributed pentasac- 
charide  sequences  (as  do  antithrombin  HI-binding  sites 
[Marcum and Rosenberg, 1989]), then a locus on heparin of 
,x,2.5 nm could span the putative heparin-binding site on the 
collagen triple helix.  In the collagen fibril, tropocollagen 
molecules are  *300-nm  long, the intermolecular spacing 
between them is ',,1.5 nm, and the length of one fibril repeat 
unit is  ,~67  nm (Brodsky and Eikenberry,  1982).  Thus, 
heparin molecules would not be long enough to span the dis- 
tance between two heparin-binding sites of adjacent 67-am 
periods (see Figs. 5 and 7). Heparin molecules would, how- 
ever, be long enough to bind to a heparin-binding site on one 
tropocollagen helix, and span the distance between this site, 
and certain cell-attachment domains on adjacent tropocolla- 
gen monomers (e.g., Fig. 7, sites marked by arrows  2  and 
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Figure 7. Diagram showing the charge density profiles of tropocol- 
lagen monomers within one 67-nm period of the type I collagen 
fibril, and the relative positions of  the putative hepafin-binding site 
and potential cell-attachment domains and argine-glyeine-aspartic 
acid (RGD) sequences.  The model of Chapman (1974) for the over- 
lap of the eel chains of rat type I collagen within the fibril was used 
as a guide to align the t~l chains of the human molecule, based on 
the high degree of sequence homology between the collagens of 
these species.  The distribution  of charged residues  of the human 
protein matched nearly exactly with those of  the rat, although it was 
necessary to delete  several nonhomologous residues  from the hu- 
man sequence to achieve alignment.  The fibril portion shown is an 
expanded diagram of the molecules within the boxed area of Fig. 
5  b,  and includes  one overlap  and one gap zone,  as  indicated. 
Horizontal bars represent segments of five overlapping triple heli- 
cal tropocollagen molecules,  with the NH2 terminus (N) of one 
monomer located at the upper left of the diagram, and the COOH 
terminus (C) of another monomer at the lower right of  the diagram; 
spacing between tropocollagen molecules is not to scale.  Vertical 
bars represent total charge density at each residue unit along each 
triple helix, i.e., these values were determined by aligning the pri- 
mary sequences  of the human type I collagen t~l  and u2 chains 
(Kuivaniemi  et al.,  1988;  Tromp et al.,  1988),  and summing the 
charges of the three aligned residues  across the chains of the triple 
helix. The location of  the proposed heparin-binding domain is indi- 
cated (black arrow). Potential  cell attachment sites and RGD se- 
quences include DGEA (arrow 1 ) (Staatz et al., 1990, 1991) oftbe 
cd chains of human,  chicken, bovine,  and rat; RGDA of the cd 
chains of  the human (arrow  2); RGDT of  the ct2 chain of  the chicken 
but not human protein (arrow 3) (Dedhar et al.,  1987; Pignatelli 
and Bodmer,  1988); RGDG of the a2 chain of the human (arrow 
4); RGDQ of the c~2 chain of the human (arrow  5); and RGDK of 
the od and ct2 chains of the human (arrow 6) (see Hulmes et al., 
1973; Bernard et al., 1983; Kuivaniemi et al., 1988; Tromp et al., 
1988 for all sequences).  Basic domain near COOH terminus show- 
ing sequence homology to proposed heparin-binding site (see Dis- 
cussion) is indicated (arrow 7). Letters and bars at bottom of figure 
3),  thereby  potentially  influencing  cell-collagen  interac- 
tions.  The precise in vivo role of HSPGs as regulators  of 
integrin  receptor-collagen  interactions  will  remain uncer- 
tain,  however,  until  the  locations  of  available  integrin- 
binding  sites  on  native  type  I  collagen  fibrils  have  been 
mapped. 
It is  of interest  to  speculate  on the  in vivo role  of the 
heparin-binding  site  of type I  collagen.  Possibly,  this  site 
functions to join extracellular  matrix PGs and collagen fi- 
brils, to give structural support to certain connective tissues, 
or to control aspects  of collagen  fibriUogenesis  (e.g.,  see 
Ruoslahti and Engvall,  1980; Vogel et al.,  1984; Ruoslahti 
and Pierschbacher,  1987; Scott and Parry,  1992).  Alterna- 
tively, the heparin-binding site of type I collagen may func- 
tion in cell adhesion, as a primary matrix receptor for cell 
surface HSPGs (Koda et al.,  1985; Sanderson et al.,  1992). 
For example, via this binding site, cell surface HSPGs may 
act as coreceptors,  by bringing extraceUular ligands (e.g., 
collagen) together with high affinity cell  surface receptors 
for these ligands (e.g.,  integrins) (see Bernfield et al.,  1992 
for review). Thus, given the abundance of HSPGs and type 
I collagen fibrils in most tissues, it is likely that the heparin- 
binding site on type I collagen participates in key physiologi- 
cal  processes  such  as  cell  adhesion,  migration,  or  cell- 
directed  assembly  or  restructuring  of  the  extracellular 
matrix. 
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